Citation Impact
Citing Papers
Characterizing and explaining the impact of disease-associated mutations in proteins without known structures or structural homologs
2022 StandoutNobel
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Breast cancer
2019 Standout
Metagenomic analysis of gut microbiota modulatory effects of jujube (Ziziphus jujuba Mill.) polysaccharides in a colorectal cancer mouse model
2019 Standout
Papillary Lesions of the Breast: An Update
2016
Hepatocellular carcinoma
2016 Standout
Histologic Grading of Noninvasive Papillary Urothelial Tumors : Validation of the 1998 WHO/ISUP System by Immunophenotyping and Follow-up
2004
High level PHGDH expression in breast is predominantly associated with keratin 5‐positive cell lineage independently of malignancy
2015
Gastric cancer—molecular and clinical dimensions
2013
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The Human Transcription Factors
2018 Standout
The ETS family of oncogenic transcription factors in solid tumours
2017
Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study
2012 Standout
Overexpression of tumour‐ssociated carbohydrate antigen sialyl‐Tn in advanced bladder tumours
2013
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Future strategies in the diagnosis, staging and treatment of bladder cancer
2003
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer
2020
A review of estrogen receptor/androgen receptor genomics in male breast cancer
2017
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Accuracy of classifying poorly differentiated non–small cell lung carcinoma biopsies with commonly used lung carcinoma markers
2015
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
2014
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Serine Synthesis Helps Hypoxic Cancer Stem Cells Regulate Redox
2016 StandoutNobel
Bacterial Biofilm and its Role in the Pathogenesis of Disease
2020 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Role of colonic microbiota in colorectal carcinogenesis: A systematic review
2015
mutation3D: Cancer Gene Prediction Through Atomic Clustering of Coding Variants in the Structural Proteome
2016
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Paula Lopes being referenced
Male breast cancer: Looking for better prognostic subgroups
2016
Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder
2003
Apocrine ductal carcinoma in situ of the breast: Histologic classification and expression of biologic markers
2001
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens
2013
Ki‐67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification
2003
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
2013
Intracystic (encysted) papillary carcinoma of the breast: A clinical, pathological, and immunohistochemical study
1998
Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer
2011
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes
2013
Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis
2012
2017
Helicobacter pylori Induces Increased Expression of Toll‐Like Receptors and Decreased Toll‐Interacting Protein in Gastric Mucosa that Persists Throughout Gastric Carcinogenesis
2012
Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin
2010